Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Hopkinson Craig C. has filed 18 SEC Form 4 filings (39 transaction rows) across 1 company, with disclosures dating back to 2025. 18 of those filings fall inside the rolling window. Most recent filing: Sep 1, 2026.
On the most recent filing, Hopkinson Craig C. is listed as EVP R&D, Chief Medical Officer at Alkermes plc. Inside the rolling window, Hopkinson Craig C. reported no open-market purchases and 14 open-market sales totaling $3.9M in ALKS. The largest disclosed transaction in the window is a sale of 9,000 ALKS shares on Jul 1, 2026, worth $464K.
Companies traded
Other insiders at ALKS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.9M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| ALKS | EVP R&D, Chief Medical Officer | Sale | 9,000 | $423K | Sep 1 | SEC ↗ | |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 9,000 | $437K | Aug 3 | SEC ↗ | |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 9,000 | $464K | Jul 1 | SEC ↗ | |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 9,000 | $375K | Jun 1 | SEC ↗ | |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 9,000 | $301K | May 2 | SEC ↗ | |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 9,000 | $320K | Apr 1 | SEC ↗ | |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 9,000 | $267K | Mar 4 | SEC ↗ | |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 9,000 | $305K | Feb 2 | SEC ↗ | |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 5,000 | $150K | Jan 8 | SEC ↗ | |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 4,000 | $112K | Jan 2 | SEC ↗ | |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 3,748 | $112K | Dec 5 | SEC ↗ | |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 4,000 | $117K | Dec 1 | SEC ↗ | |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 9,000 | $273K | Nov 3 | SEC ↗ | |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 9,000 | $284K | Oct 15 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 filings has Hopkinson Craig C. made?
Hopkinson Craig C. has filed 18 SEC Form 4 filings (39 transaction rows) across 1 company since 2025.
Which companies does Hopkinson Craig C. trade?
Hopkinson Craig C. has filed SEC Form 4 disclosures for 1 company, including ALKS.
When was Hopkinson Craig C.'s most recent SEC Form 4 filing?
Hopkinson Craig C.'s most recent SEC Form 4 filing on Tracefour is dated Sep 1, 2026.
What is Hopkinson Craig C.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Hopkinson Craig C. is listed as EVP R&D, Chief Medical Officer.
What is Hopkinson Craig C.'s total buy and sell value in the current window?
Inside the rolling retention window, Hopkinson Craig C. bought $0 and sold $3.9M based on SEC Form 4 filings.
What was Hopkinson Craig C.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 9,000 ALKS shares on 2026-07-01, worth $464K, per SEC Form 4 filings.